register

News & Trends - MedTech & Diagnostics

Medtronic Chairman & CEO unveils bold vision for the future of healthcare

Health Industry Hub | June 19, 2023 |

MedTech & Diagnostics News: Taking centre stage in a captivating podcast, global Chairman & CEO of Medtronic, Geoff Martha, sheds light on his recent visit to Australia to celebrate Medtronic’s 50th anniversary in the country.

The interview explores the multifaceted aspects of Medtronic’s business performance, including its social impact initiatives and sustainability goals. Delving deeper, Martha who leads the $32 billion medtech company and its 95,000 employees, addresses the challenges faced by the medical technology sector and reveals the key trends shaping the future of healthcare.

The interview kicks off with Martha sharing key highlights from Medtronic’s full-year financial results and the current issues in the medtech sector.

He acknowledges the importance of Australia as a market for Medtronic and the significant impact that Medtronic ANZ has had on the local healthcare ecosystem. He said “It’s a big market and an important part of our innovation ecosystem for medtech.”

He highlights the potential of technology, particularly AI, to drive meaningful change in healthcare. He states, “I really believe that technology is the way forward to solve these issues. AI can help solve access issues, improve outcomes, and personalise healthcare.” He also stresses the need for collaboration with key stakeholders and safeguarding data for the ethical use of technology.

Martha calls on policymakers to invest time in understanding the health economics of innovative medical technologies. He emphasises that viewing these innovations as costs is a misconception; they are investments with favourable health economics. He invites policymakers to engage with the medtech sector, listen to the data-driven insights, and collaborate to ensure timely access to novel health technologies for patients.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.